• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症研究VII. 17β-羟基-4-雌烯-3-酮17-癸酸酯对实验性骨质疏松症的影响。

Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis.

作者信息

Robin J C, Suh O W, Ambrus J L

出版信息

Steroids. 1982 Aug;40(2):125-32. doi: 10.1016/0039-128x(82)90026-5.

DOI:10.1016/0039-128x(82)90026-5
PMID:7157449
Abstract

Total body neutron activation analysis was employed to measure total calcium in C3H/St (Ha) female mice. Ninety-nine percent of total body calcium is in bone and loss of calcium was used as an index of osteoporosis. Heparin (500 U/kg B.I.D.) treatment for three months resulted in significant osteoporosis. 17 beta-Hydroxy-4-estren-3-one 17-decanoate 1.5 mg/kg or 4 mg/kg twice monthly prevented this heparin accelerated osteoporosis. The results suggest that 17 beta-hydroxy-4-estren-3-one 17-decanoate may be capable of preventing bone loss and partially increasing bone mass in patients exposed to osteoporosis inducing regimens.

摘要

采用全身中子活化分析法测量C3H/St(Ha)雌性小鼠的总钙含量。全身钙的99%存在于骨骼中,钙的流失被用作骨质疏松症的指标。肝素(500 U/kg,每日两次)治疗三个月导致明显的骨质疏松症。17β-羟基-4-雌烯-3-酮17-癸酸酯以1.5 mg/kg或4 mg/kg的剂量每月两次给药可预防这种肝素加速的骨质疏松症。结果表明,17β-羟基-4-雌烯-3-酮17-癸酸酯可能能够预防接受诱发骨质疏松症方案治疗的患者的骨质流失并部分增加骨量。

相似文献

1
Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis.骨质疏松症研究VII. 17β-羟基-4-雌烯-3-酮17-癸酸酯对实验性骨质疏松症的影响。
Steroids. 1982 Aug;40(2):125-32. doi: 10.1016/0039-128x(82)90026-5.
2
Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis.骨质疏松症研究VI. 人降钙素和鲑鱼降钙素对实验性骨质疏松症的影响。
Res Commun Chem Pathol Pharmacol. 1982 Mar;35(3):491-8.
3
The effects of nandrolone decanoate on rarefying bone tissue.癸酸诺龙对骨质稀疏组织的影响。
Curr Med Res Opin. 1980;6(9):606-13. doi: 10.1185/03007998009109496.
4
Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
Maturitas. 1986 Dec;8(4):281-9. doi: 10.1016/0378-5122(86)90036-8.
5
Studies on osteoporoses. XII. Effect of imidazoquinazolinones on experimental osteoporosis. A preliminary report.骨质疏松症研究。十二。咪唑喹唑啉酮对实验性骨质疏松症的影响。初步报告。
J Med. 1982;13(5-6):465-72.
6
Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
Calcif Tissue Int. 1987 Jul;41(1):7-10. doi: 10.1007/BF02555124.
7
Studies on osteoporosis. IX. Effect of fluoride on steroid induced osteoporosis.骨质疏松症研究。IX. 氟对类固醇诱导的骨质疏松症的影响。
Res Commun Chem Pathol Pharmacol. 1982 Sep;37(3):453-61.
8
Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.癸酸诺龙、1α-羟基维生素D3或间歇性钙剂输注疗法对症状性骨质疏松症患者骨矿物质含量、骨重塑及骨折率的长期影响:一项双盲对照研究
Bone Miner. 1986 Sep;1(4):347-57.
9
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.癸酸诺龙:骨质疏松症的药理特性及治疗用途。
Clin Rheumatol. 1995 Sep;14 Suppl 3:32-9. doi: 10.1007/BF02210686.
10
Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?绝经后骨质疏松症的治疗:合成代谢类固醇癸酸诺龙是一个候选药物吗?
Bone Miner. 1989 Apr;6(1):77-86. doi: 10.1016/0169-6009(89)90025-1.

引用本文的文献

1
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.癸酸诺龙:骨质疏松症的药理特性及治疗用途。
Clin Rheumatol. 1995 Sep;14 Suppl 3:32-9. doi: 10.1007/BF02210686.
2
Adverse effects of anabolic steroids.合成代谢类固醇的不良反应。
Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):254-71. doi: 10.1007/BF03259912.